Company profile
STRATA Skin Sciences, Inc.
OTC: SSKN · Healthcare · Medical - Devices
#502 of 1,418 Healthcare companies by revenue33rd-percentile growth
EA Score
52DFH 52DQ 55GM 48SS 48
v0.1 · 65/100 weight · provisional
↑ disclosure history, Piotroski F · ↓ market scale, return on equity
Methodology →Revenue TTM
$30.7M
Rev growth YoY (TTM)
-8.5%
Net income (FY)
-$6.3M
Employees
114
as of 2026-08-26
Market cap
$465
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$30.7M$30.7M2025
Net income-$6.3M-$6.3M2025
Operating income-$4.7M-$4.7M2025
Total assets$30.5M$30.5M2025
Liabilities$27.6M$27.6M2025
Equity$2.9M$2.9M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is STRATA Skin Sciences, Inc.’s revenue?
STRATA Skin Sciences, Inc. booked $30.7M in FY2025 revenue, contracting 8.5% year over year — slower than 67% of Healthcare companies we track, at a -20.4% net margin.
Peers · Healthcare
Foghorn Therapeutics Inc.47DScripsAmerica, Inc.——BioSyent Inc.83B+YourWay Cannabis Brands Inc.——Synergy CHC Corp.35DScilex Holding Company28DNeighbors
Montgomery →Key facts
CEOErica Jordan
SectorHealthcare
IndustryMedical - Devices
HeadquartersHorsham, PA
ExchangeOTC: SSKN
Employees114
IPO date2005-11-03
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.